Related Experiment Video

Updated: Jun 10, 2026

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
13:36

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes

Published on: October 20, 2023

[Effects of Sema3A derived from tumor cells on functions of dendritic cells]

Xie-lai Zhou1, Yin Huang, Fang Wang

  • 1Department of Basic Medicine, Hangzhou Normal University, Hangzhou 310036, China.

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|August 24, 2010
PubMed
Abstract

Insights

Tumor cells secrete Semaphorin 3A (Sema3A) to suppress dendritic cell (DC) maturation and function. Inhibiting Sema3A enhances DC immune responses, suggesting a role in tumor immune evasion.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Signaling

Context:

  • Dendritic cells (DCs) are crucial for initiating adaptive immune responses.
  • Tumor cells often employ mechanisms to evade immune surveillance.
  • Semaphorin 3A (Sema3A) is implicated in various biological processes, including immune modulation.

Purpose:

  • To investigate the impact of tumor cell-secreted Sema3A on murine dendritic cell (DC) immunological functions.
  • To determine if Sema3A secreted by lung adenocarcinoma cells affects DC maturation and T cell activation.

Summary:

  • Lung adenocarcinoma A549 cells were manipulated to alter Sema3A secretion using small interference RNA (Si-Sema3A).
  • Supernatants from these cells were applied to DCs, and their immunophenotypes, IL-12P70 production, and T cell activation capabilities (IFN-gamma, IL-2 secretion) were assessed.
  • Reduced Sema3A levels led to increased DC expression of MHC, CD40, CD80, enhanced IL-12P70 production, and improved activation of antigen-specific T cells.

Impact:

  • Tumor-derived Sema3A actively inhibits DC maturation and function.
  • This inhibition may represent a mechanism of immune evasion utilized by tumor cells.
  • Targeting Sema3A could potentially enhance anti-tumor immunity.

More Related Videos

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus09:04

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...